Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to $9.1 million.

  • Janux Therapeutics' Prepaid Assets rose 968.64% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 968.64%. This contributed to the annual value of $8.5 million for FY2024, which is 6291.96% up from last year.
  • Janux Therapeutics' Prepaid Assets amounted to $9.1 million in Q3 2025, which was up 968.64% from $9.5 million recorded in Q2 2025.
  • Janux Therapeutics' 5-year Prepaid Assets high stood at $9.5 million for Q2 2025, and its period low was $2.0 million during Q2 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $5.5 million (2022), whereas its average is $5.8 million.
  • Per our database at Business Quant, Janux Therapeutics' Prepaid Assets skyrocketed by 72489.96% in 2021 and then plummeted by 387.24% in 2023.
  • Quarter analysis of 5 years shows Janux Therapeutics' Prepaid Assets stood at $2.1 million in 2021, then skyrocketed by 164.02% to $5.4 million in 2022, then dropped by 3.87% to $5.2 million in 2023, then surged by 62.92% to $8.5 million in 2024, then grew by 7.06% to $9.1 million in 2025.
  • Its Prepaid Assets was $9.1 million in Q3 2025, compared to $9.5 million in Q2 2025 and $9.2 million in Q1 2025.